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Abstract
Studies in rodents have shown that dietary modifications as mammary glands (MG) develop, regulates susceptibility to
mammary tumor initiation. However, the effects of dietary PUFA composition on MGs in adult life, remains poorly
understood. This study investigated morphological alterations and inflammatory microenvironments in the MGs of adult
mice fed isocaloric and isolipidic liquid diets with varying compositions of omega (ω)-6 and long-chain (Lc)-ω3FA that
were pair-fed. Despite similar consumption levels of the diets, mice fed the ω-3 diet had significantly lower body-weight
gains, and abdominal-fat and mammary fat pad (MFP) weights. Fatty acid analysis showed significantly higher levels of
Lc-ω-3FAs in the MFPs of mice on the ω-3 diet, while in the MFPs from the ω-6 group, Lc-ω-3FAs were undetectable.
Our study revealed that MGs from ω-3 group had a significantly lower ductal end-point density, branching density, an
absence of ductal sprouts, a thinner ductal stroma, fewer proliferating epithelial cells and a lower transcription levels of
estrogen receptor 1 and amphiregulin. An analysis of the MFP and abdominal-fat showed significantly smaller adipo-
cytes in the ω-3 group, which was accompanied by lower transcription levels of leptin, IGF1, and IGF1R. Further,
MFPs from the ω-3 group had significantly decreased numbers and sizes of crown-like-structures (CLS), F4/80+
macrophages and decreased expression of proinflammatory mediators including Ptgs2, IL6, CCL2, TNFα, NFκB, and
IFNγ. Together, these results support dietary Lc-ω-3FA regulation of MG structure and density and adipose tissue
inflammation with the potential for dietary Lc-ω-3FA to decrease the risk of mammary gland tumor formation.
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Highlights
?• Dietary long-chain omega-3 fatty acids (Lc-ω-3FAs) modulate mam-
mary ductal end-point density and branching density in adult mice com-
pared to mice receiving a highω-6 FA containing diet.
• Dietary Lc-ω-3FAs downregulate the levels of proinflammatory cyto-
kines, adipokines and growth factors and their receptors in association
with decreased epithelial cell proliferation as compared to mice main-
tained on a high omega-6 (ω −6) FA containing diet
•Dietary Lc-ω-3FAs regulate themammary fat pad (MFP) FA profile and
is associated with adipocyte hypertrophy
• Dietary Lc-ω-3FAs decrease MG and abdominal adipose tissue inflam-
mation relative to mice receiving a high ω-6 FA containing diet.
* James E. Talmadge
jtalmadg@unmc.edu
1 Department of Pathology and Microbiology, University of Nebraska
Medical Center, Omaha, NE, USA
2 Department of Internal Medicine, University of Nebraska Medical
Center, Omaha, NE, USA
3 Veteran Affairs Nebraska-Western Iowa Health Care System,
Omaha, NE, USA
4 Department of Genetics, Cell Biology and Anatomy, University of
Nebraska Medical Center, Omaha, NE, USA
5 Department of Pharmacy Practice, University of Nebraska Medical
Center, Omaha, NE, USA
6 Department of Biochemistry, University of Nebraska-Lincoln,
Lincoln, NE, USA







IGF Insulin like growth factor
Lc Long-chain
MFP Mammary fat pad
MG Mammary gland
MUFA Monounsaturated fatty acid
PUFA Polyunsaturated fatty acid
qRT-PCR Quantitative real-time polymerase chain reaction
SFA Saturated Fatty Acid
SPF Specific pathogen free
TEB Terminal end bud
Introduction
A growing body of evidence suggests a linkage between
mammary gland (MG) development and diet [1] that can also
modify breast cancer risk [2]. The majority of studies into
dietary PUFA regulation of MG development have been un-
dertaken with in-utero, fetal, post-natal and prepubertal ma-
nipulated rodents but are rarely undertaken in adult mice.
These studies have shown that feeding a long-chain omega-
3 fatty acid (Lc-ω-3FA; fish oil) containing diet reduces the
number of terminal end buds (TEB), which are a marker of
MG development [3–5]. Indeed, rodent studies have sug-
gested that ω-6 and ω-3 PUFA have opposing effects on
TEB formation, with ω-3 FA reducing the number of TEBs
[1, 5, 6] and mammary gland-density [7], while highω-6 FA
diets reduce the differentiation of TEBs to alveolar buds [3].
During puberty, the majority of TEBs differentiate into termi-
nal ducts or alveolar buds, while lateral branching of MG
ducts occurs post-pubertal. As tumor initiation typically oc-
curs post pubertal it is critical to study the effect of PUFA on
MG differentiation in adult mice. Further, it is critical that
studies into dietary regulation of MG development be under-
taken using iso-lipidic diets differing only in PUFA composi-
tion [5]; specifically, the presence or absence of Lc-ω-3FA. It
is clear that dietary PUFA composition can regulate carcino-
genesis and tumor progression [8]; however, the potential for
dietary epigenetic modification of molecular targets, in early
life, requires additional investigation [9] as do the effects on
post-pubertal MG structure and composition.
Mammary fat pads (MFP) in rodents are comprised of ep-
ithelial cells in the MG (or ductal tree), and adipose tissue,
stroma and extracellular matrix which provides physical sup-
port for the MG ductal network [10]. Recently, mammary
adipocytes have also been shown to have an active role in
the chronic inflammation [11] that is associated with adipo-
cyte IL-6 secretion, and likely plays a regulatory role in
mammary cancer induction and progression [12, 13].
Adipocytes within the MFP contribute to the regulation of
MG development. For example, in the absence of mammary
fat in A-ZIP/F-1 transgenic mice, abnormal MG development
occurs [14]. MG adipocytes also regulate changes in mamma-
ry tissue during pregnancy, lactation, and involution, via local
signals between mammary epithelium and adipocytes [12].
Emerging research suggests that the timing of PUFA expo-
sure is critical to the increased risk of mammary cancer [15].
As MG development is age-dependent, specifically during
puberty; most studies to date have used pre-pubertal exposure
[1, 6]. These studies have demonstrated that pre-pubertalω-3
PUFA incorporation into the MG regulates the morphological
development of the MG during puberty, [6] and reduces mam-
mary tumorigenesis [16]. However, the role of dietary Lc-ω-
3FA exposure in post-pubertal life, and its regulation of the
MG stromal microenvironments and morphogenesis is little
studied.
Based on these observations, we examined the hypothesis
that dietary Lc-ω-3FA regulates mammary gland morpholo-
gy. We report that in the absence of dietary Lc-ω-3FA the FA
composition within the adipose tissue of MG varies, resulting
in local-regional inflammation; increased ductal branching
density and mammary epithelial cell proliferation, all of which
may potentially contribute to MG carcinogenesis.
Materials and Methods
Animals, Diet and Tissue Collection
Female BALB/c mice (6 weeks old) purchased from Charles
River Laboratories were housed in groups of five, under stan-
dard conditions of temperature and humidity, with a 12 h light-
dark cycle. The mice were caged in micro-isolators under
HEPA filter air supply. Routine health monitoring was under-
taken to ensure specific pathogen-free (SPF) conditions. The
Institutional Animal Care and Use Committee at the
University of Nebraska Medical Center approved the animal
protocol for this study.
Following shipment and acclimation for about 4 weeks, 10-
week old mice were randomly divided into the experimental
dietary groups; omega-6 (ω-6) and omega-3 (ω-3) (n = 20).
The ω-6 diet consisted of the Lieber-DeCarli control diet
(Dyets # 710027) containing 28.4 g/L olive oil; while the ω-
3 diet was customized by using the base diet (Dyets # 710166)
without olive oil and adding; 8.4 g/L olive oil and 20 g/L of
fish oil (NutriGold Triglyceride Omega-3 Gold capsules; Lot#
0081–3180-2) (Table 1). Both liquid diets provided 1.0 Kcal
energy per ml of diet and equal calories from macronutrients
(35% derived from fat, 47% from carbohydrate, and 18%
from protein). The ω-6 and ω-3 diets were iso-caloric and
iso-lipidic diets, differing primarily by the absence or presence
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of Lc-ω-3FA from fish oil and olive oil respectively. Omega-3
capsules and Lieber-DeCarli powder diets were stored at 4 °C
for up to 2 weeks and at −20 °C for longer times. Diets were
prepared and delivered every 24–26 h, and daily consumption
monitored. The diets were given using the pair-fed model as
described previously [17]. Briefly, ad libitum access to the
liquid diets was provided for the first five days for acclimati-
zation. From day six forward, the ω-6 diet group mice were
pair-fed based on the mean consumption of theω-3 diet group
from the previous day, and continued throughout the study for
10 or 20 weeks. Body weights were determined and recorded
every week. At the end of the experiment, the fourth MFP and
abdominal fat tissue were removed, weighed and processed.
Fatty Acid Analysis of Diets and Tissues
Portions of freshly collected MFP tissues were snap frozen
and stored at -80 °C until used for FA analysis. Total lipid
extraction from tissues used antioxidant β-hydroxy-toluene
(0.05%, wt/vol) as previously described [17–19].
Heptadecanoic and nonadecanoic acid (100 μg each) were
added to all samples to estimate the recovery of FA.
Methanol (0.5 ml) containing 1% (wt/vol) sulfuric acid and
0.25ml of toluene, was added to each sample and incubated at
60 °C overnight to hydrolyze complex lipids and methylate
FA. Following incubation, 1.25 ml of water containing sodi-
um chloride (5%, wt/vol) was added and esters extracted using
hexane (2 × 1.25 ml per sample). The hexane layer was
washed using one ml of water containing potassium
bicarbonate (2%, wt/vol), and dried over anhydrous sodium
sulfate. The solvent was removed under nitrogen and the FA
methyl esters analyzed by gas chromatography-mass spec-
trometry (GC-MS) using an Agilent 6890 series gas chro-
matograph equipped with a 5873 mass-selective detector.
The FA concentration was analyzed and reported as μg/ml
or μg/mg of the sample and compared between diets and
tissues from ω-3 and ω-6 dietary treatment groups.
Histology and Immunohistochemistry (IHC)
MFP and abdominal fat tissues were fixed in zinc fixative for
24–48 h, and transferred to 70% ethanol and then embedded
in paraffin, and sectioned at 4–6 μm. Sections were stained
with hematoxylin and eosin (H & E), examined under light
microscopy using a Zeiss Axioplan-2 microscope with a HRc
camera, and analyzed using Zeiss AxioVision Rel 4.8 soft-
ware. Two independent investigators examined the sections
as Bblinded^ group assignments and an experienced patholo-
gist validated the results. Adipocyte size analysis was per-
formed using MRI_Adipocyte_Tools, a plug-in tool from
Image-J as per the software protocol using H & E stained
sections of MFP. Images were captured from 10 randomly
selected fields at 100× magnification. The adipocyte area
was analyzed, as above, such that mean adipocytes area from
the 10 fields/mouse and the mean number of adipocytes/100×
field [n = 5] was calculated. Images were captured at 200X
and used for the adipocytes size analysis from the abdominal
fat tissue. Crown like structures (CLS) were identified as adi-
pocytes with at least two infiltrating immune cells (macrophage
morphology) around the cell in H & E stained MFP sections.
Rabbit polyclonal antibody to F4/80 (ab100790 Abcam
Inc., Cambridge, MA) was used to detect infiltrating macro-
phages, and rabbit monoclonal antibody to Ki67 (ab16667,
Abcam Inc.) was used as a marker of proliferating cells. For
IHC staining, MFP tissue sections were deparaffinized,
rehydrated and antigen retrieved by sodium citrate method
as described previously [17]. The slides were washed in
TRIS-buffered saline, pH 7.6 (TBS) containing Tween-20
(TBST) and endogenous peroxidase/phosphatase was blocked
with BLOXALL (SP6000, Vector labs, Burlingame, CA).
Non-specific reactions were blocked using 2.5% normal horse
serum blocking solution (S-2012, Vector labs) for 30 min at
room temperature (RT). Primary antibodies were diluted in
antibody diluent (559,148; BD Bioscience), and the slides
incubated with antibody overnight at 4 °C. For negative con-
trols, serial sections were processed in the absence of primary
antibody but with all other reagents. Following primary anti-
body incubation and washing the sections were incubated in
ImmPRESS-AP, anti-rabbit Ig (MP-5401, Vector labs) for
30 min at RT in a humid chamber. Staining was detected using
ImmPACT Vector Red alkaline phosphatase reagent (SK-
5105) and counterstained with hematoxylin solution
Table 1 Composition of the diets: The omega-6 diet (ω-6 diet) is the
Lieber-DeCarli control diet, which contains 28.4 g/L of olive oil. Omega-
3 diet (ω-3 diet) was customized by replacing 20 g/L olive oil with theω-
3 oil (NutriGold omega 3 capsule). All the other components were the
same in both of the diets to maintain iso-composition and iso-caloric
properties





Corn oil 8.5 8.5
Olive oil 28.4 8.4
Safflower oil 2.7 2.7
Maltose dextrin 115.2 115.2
Cellulose 10 10
Mineral mix 8.75 8.75
Vitamin mix 2.5 2.5
Choline bitartrate 0.53 0.53
Xanthum gum 3 3
Encapsulated omega-3 oil 0 20
Total 221.8 221.8
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(MHS32; Sigma-Aldrich, St. Louis, MO) followed by 0.1%
sodium bicarbonate. Images were captured on a Zeiss
Axioplan-2 microscope as described above. The number of
F4/80+ cells in adipose tissue and Ki67+ cells in mammary
ductal epithelium were counted using 100× fields in 10 ran-
dom fields per sample (n = 5).
Whole-Mount Analysis of MG
The intact inguinal MGs (MGs) (#4) were excised from
mice at necropsy. The MGs were spread onto a glass slide
immediately after collection and fixed in Carnoy’s solu-
tion (100% EtOH, chloroform, glacial acetic acid; 6:3:1)
for 4 h in the fume hood at room temperature (RT). The
fixed MGs were then gradually rehydrated in graded eth-
anol (70%, 35%, 15%) ending in water. The MGs were
stained in carmine alum staining solution [0.2% Carmine
(C6152, Sigma, MO) and 0.5% aluminum potassium sul-
fate dodecahydrate (#237086, Sigma, MO) with a few
flakes of thymol (#16254, Sigma, MO) overnight. The
stained MGs were washed in water and dehydrated in
ascending graded ethanol solution (50%, 70%, 95%,
100%), cleared by incubating in xylene overnight and
mounted with Permount (SP 15–100, Fisher scientific).
Who l e s l i d e image s we r e a cqu i r ed us i ng the
Invitrogen™ EVOS™ FL Auto Imaging System. For
quantitative analysis, higher magnification images were
acqui red us ing the Zeiss Discovery V8 Stereo
Microscope with Axiocam 105 color camera. We used
the term Bductal terminus/termini^ for all the end struc-
tures of ducts and ductules present in the high power field
(HPF). The number of ductal termini were counted in 10
images (40× magnification) per sample and used to cal-
culate the average value for each sample. The extent of
ductal branching was analyzed by counting the total num-
ber of lateral branches in 3–4 primary ducts and five sec-
ondary ducts (between lymph node and distal ends of
ducts) at 12.5× magnification. The results were expressed
as a number of lateral branches per mm of a duct (prima-
ry/secondary). The quantitative results of ductal termini
and lateral branching were discussed as ductal end-point
density and branching density respectively as described
previously [20] The total area of MG ductal tree, the
length of the primary duct (from nipple to end of the duct)
and lymph node area were quantified by using Image-J
software.
Quantitative Real Time PCR Analysis
Tissues were collected in RNA stabilizing solution,
RNAlater (#76106, Qiagen) and stored at -20 °C until
use. RNA was extracted by using TRIzol reagent
(15,596,026, Invitrogen). RNA concentration was
measured by using NanoDrop (ND1000, Thermofisher).
In order to confirm the integrity of the RNA, the RNA
(2 μg) was separated in a denaturing agarose gel (1%) in
formaldehyde, and samples with two distinct bands of
RNA (16S and 23S) in the gel were used for further anal-
ysis. Complimentary DNA (cDNA) was prepared from
RNA by using high-capacity cDNA synthesis kit
(4,374,966, Applied Biosystems; AB) as per company pro-
tocol. The qRT-PCR master mix was prepared using
TaqMan gene expression master mix (4,370,074, AB),
anti-mouse probes and 10 ng of cDNA in Micro Amp fast
optical 96 wells plate (4,346,906, AB). The samples were
run using StepOnePlus qPCR machine (Applied
Biosystems). Pre-synthesized mouse probes from
Thermofisher were used for the study. The probes used in
the study were; GAPDH (Mm99999915_g1), IGF1
(Mm00439560_m1), IGF1R (Mm00802831_m1), ESR1
(Mm0 0 4 3 3 1 4 9 _m 1 ) , a m p h i r e g u l i n ( AREG ;
M m 0 1 3 5 4 3 3 9 _ m 1 ) , T N F a l p h a ( T N F α ;
Mm00443258_m1), CCL2 (Mm00441242_m1), leptin
(Lep; Mm00434759_m1) ; ad iponec t in (Adipoq;
Mm004 56 4 2 5 _m1 ) , I L 6 (Mm004 4 6 19 0 _m1 ) ,
P ros t ag l and in -endope rox ide syn thase (PTGS2;
Mm00478374_m1) , i n t e r f e r on gamma ( IGFγ ;
Mm01168134_m1),NFkB1 (Mm00476361_m1) proges-
terone receptor (PGR; Mm00435628_m1) and prolactin
(PRL; Mm0059950_m1). Negative controls were run for
every probe in the plate. Each qRT-PCR experiment was
carried out in triplicate, and average cycle thresholds (Cts)
were obtained for each dietary group of MFP (n = 14) and
abdominal fat (n = 8). The relative quantity of target
mRNA was determined using the Levak method [21].
Briefly, the Ct of GAPDH was subtracted from the Ct value
of the target to obtain delta (d) Ct. Then the dCt of each
of the samples, from the ω-6 group, was compared with
the average dCt from the ω-3 group to get ddCt values.
The fold change between the samples was calculated as 2-
ddCt as described previously [21].
Statistical Analysis
Results were expressed as a mean ± standard error of the
mean (SEM) for animal weights, MFP/abdominal fat
weight or weight/body weight, fatty acid levels, histology
and IHC quantification values. Data from the two groups
were compared by Student’s t-test for independent samples
or Mann Whitney’s test. Plots for change in body weights
were compared by repeated measures analysis. All graphs
were plotted using Sigma Plot. All data were analyzed
using SPSS for statistical significance. For qRT-PCR data,
fold-change values were compared by one-sample t-test. In
all instances, differences where p ≤ 0.05 were considered to
be statistically significant.
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Results
Food Consumption, Body Weight, and MG
and Abdominal Fat Weights
Pair-feeding was undertaken, as described previously [17], to
assure iso-caloric and iso-lipidic consumption. To acclimate
the mice to a liquid diet, the first five days of feeding was ad
libitum. During this time, average liquid diet intake was
assessed daily, with the observation of increased diet con-
sumption of the ω-6 diet. Based on this observation, the ω-
3 diet consumption was used as the baseline for pair feeding.
During this five-day period of ad libitum feeding the ω-6
group of mice gained more weight than the ω-3 group in
association with increased liquid diet consumption.
Following the initiation of pair feeding, on day 6, no signifi-
cant differences in food intake occurred between the dietary
groups. (Fig. 1a). The initial body weights were comparable
between the dietary groups. However, mice (n = 20) on theω-
3 diets had a significantly lower body weight gain throughout
the study (Fig. 1b), despite the use of iso-caloric diets. The
weights of the abdominal fat in the mice on theω-3 diet were
45% lower (Fig. 1c) and 42% lower as abdominal fat weight
relative to the body weight (Fig. 1d) compared to the ω-6
group (n = 8) (both p < 0.05). Similarly, the weight of the
fourth (left inguinal) MGs were assessed after the mice were
fed the diets for 20 weeks (n = 10). Significant decreases in the
MG weights (−43%) (Fig. 1e) and MG weight relative to the
body weight (−41%) (Fig. 1f) were observed in the mice on
the ω-3 diets compared to the MGs from the mice receiving
the ω-6 diets (p < 0.05) (n = 10).
Modulation of MG, FA Profile by the ω-3 Versus ω-6
Iso-Lipidic PUFA Diets
The FA composition of the diets and MFPs are shown in
Table 2. There was a significant effect of the dietary FA com-
position on the lipid profile of the MFPs from mice fed the
diets for 10 weeks. The ratio of ω-6:ω-3 FA of the ω-6 and
ω-3 diet were 21:1 and 0.7:1 respectively. The ω-6 diet did
not have detectable levels of Lc-ω-3FA such as;
eicosatetraenoic acid (EPA) and docosahexaenoic acid
(DHA), which were major sources ofω-3 FA in theω-3 diet.
Consistent with the dietary FA composition, significantly
higher levels of ω-3 FAs such as LNA (0.7 ± 0.2), EPA
(11.1 ± 1.2) and DHA (7.5 ± 0.6) μg/mg were observed in
the MFPs of mice fed the ω-3 diet. In contrast, all ω-3 FAs
were below the detection levels in the MFPs of the ω-6 diet
fed mice. The levels ofω-6 FAs were not significantly differ-
ent between mice fed ω-6 and ω-3 diets, nor in the MFPs
from mice fed the respective diets. However, a lack of Lc-ω-
3FAs in the ω-6 diet significantly increased the ratio of ω-
6:ω-3 FA in MFPs from the mice fed the ω-6 diet. Besides
PUFA, the levels of total saturated fatty acid (SFA) were in-
creased (1.5 fold), and oleic acid (a major monounsaturated
fatty acid from olive oil) was decreased (1.5 fold) in MFPs
frommice fed anω-3 diet compared to the levels inMFP from
the ω-6 diet group. The total levels of FAs were similar be-
tween the ω-6 and ω-3 diets and not significantly different
between the MFPs from the mice fed the diets.
Dietary PUFA Regulation of Mammary Ductal
Branching
A histopathologic analysis of the inguinal MFPs of mice fed
the diets for 20 weeks, was performed to evaluate structural/
morphological alterations inMGs. (n = 10). A significant mor-
phological difference was observed in the ductal tree network
and the total glandular area between the two dietary groups
(Fig. 2a and b). The total area of theMG tree ofMFPs fromω-
3 fed mice was 20% smaller (143.3 ± 10.4mm2) relative to the
area of the MFPs from ω-6 fed mice (177.6 ± 11.8 mm2)
(p < 0.05) (Fig. 2c). A comparison of the quantitative differ-
ences in the ductal tree compared the number of ductal termini
(end-point density) and the extent of lateral branching
(branching density). Since the mice used in the study were
post-pubertal adults, TEBs had differentiated into terminal
ducts, alveolar buds or end buds and we use the term ductal
termini for these end structures. MFPs from mice fed theω-3
diet had 63% fewer ductal termini/HPF (25.9 ± 1.9) compared
to the numbers in the MFPs fromω-6 diet fed mice (70.9 ± 5;
p < 0.05) (Fig. 2d). Similarly, there were significantly fewer
lateral branches per mm of primary ducts (0.7 ± 0.1) (a 60%
decrease) and secondary ducts (1.3 ± 0.1) (a 65% decrease)
compared to the numbers in each mm of primary duct (1.7 ±
0.1) and secondary ducts (3.8 ± 0.2) of MFPs from the ω-6
diet fed group (Fig. 2e). In the microscopic analysis, there was
a significant difference in the ductal morphology, including
the presence of ductal sprouts, along the ductal wall in
MFPs fromω-6 diet fed mice, which were absent in the ducts
of theMFPs fromω-3 diet fed mice. Despite the differences in
lateral branching, there were no significant differences in the
length of the primary ducts in mice fed the ω-3 diet (25.9 ±
1.2 mm) compared to the primary ductal length (28.1 ±
1.6 mm) in MFPs from ω-6 diet fed mice. Similarly, the av-
erage lymph node (LN) area (2.7 ± 0.1 mm2) of the ω-3 diet
fed mice were not significantly different from the LN area
(2.7 ± 0.3 mm2) of ω-6 diet fed mice.
Dietary PUFA Regulation of Ductal Epithelial Cell
Proliferation
The ductal histology of the MFPs from mice, fed each of
the diets for 20 weeks, were analyzed using Mason’s
trichrome stain and proliferating epithelial cells assessed
by Ki67 staining. As shown in a representative Mason’s
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trichrome stained MG duct (Fig. 3a), we analyzed ductal
lumen (DL) area, ductal epithelium (DE) area and ductal
connective tissue (blue stained) or ductal stroma (DS) ar-
ea. The ω-3 diet feeding for 20 weeks (Fig. 3b – e) re-
sulted in a 34% decrease in the DE area (1883.3 ±
145.0 μm2) and a 54% decrease in the DS area (3034.5
± 377.9 μm2), compared to the DE area (2863 ±
189.6 μm2) and the DS area (6593.1 ± 493.9 μm2) respec-
tively from mice fed the ω-6 diets for the same duration
(p < 0.05). Further, the effects on ductal size, based on a
comparison of the ductal lumen (DL) area between the
dietary groups, documented that mice fed an ω-3 diet
had 42% smaller ducts with an average DL area of
1497.1 ± 243.6 μm2, compared to the MFPs from ω-6
fed mice, (2568.7 ± 380.9 μm2) (p < 0.05). As there were
significant differences in ductal size, we further evaluated
the area of DE and DS relative to the DL. The results
showed that the DS relative to DL were 33% smaller in the
MFPs ofω-3 diet fed mice (3.6 ± 0.3) compared to the same in
MFPs of theω-6 group (5.3 ± 0.5) (Fig. 3f) (p < 0.05). However,
there was no significant difference in the DE relative to
DL area between the dietary groups (Fig. 3g). These
results suggest that the differences in ductal connective
tissue were independent of ductal size; however, the
size of ducts between the dietary groups might affect
the DE area. Thus, proliferating epithelial cells were
evaluated to confirm the effect of dietary PUFA on
DE, which showed there were 88% fewer proliferating
cells in the DE of ω-3 diet fed mice (1 ± 0.5) compared
to ω-6 diet fed mice (8.3 ± 3.1) (Fig. 3h – j) (p < 0.05).
The regulation of estrogen signaling is one mechanism
of epithelial proliferation in MG ducts. To address this we
assessed the relative mRNA expression of amphiregulin
(AREG) and estrogen receptor-1 (ESR1) as a potential mech-
anism for the dietary PUFA regulation of DE cell proliferation.
These studies revealed that the MFPs from mice fed the ω-6
diet had 3.1-fold and 1.4-fold higher transcription levels of
AREG and ESR1, respectively, compared to MFPs from
age-matched, iso-caloric ω-3 diet fed mice (Fig. 3k).
However, there were no differences in the levels of progester-
one receptor, and prolactin mRNA levels were below the level
of detection (data not shown).
Fig. 1 Effects of Lc-ω-3FA on
body weight, MG weight, and
abdominal fat deposits: Mice
were pair-fed omega-6 (ω-6) and
omega-3 (ω-3) PUFA diets for
10–20 weeks [n = 20/group]. The
average amount of diet
consumed/day (a). Differences in
percent changes in body weights
between the pair-fed groups
compared by a repeated measure
test (b). Differences in abdominal
adipose tissues deposits (c) [n =
10/group], and abdominal fat
weight relative to the body weight
(d). Weights of the fourth rear
MG at the age of 30 weeks (e).
MG weight relative to body
weight (f) [n = 10/group]
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Dietary PUFA Regulation of MFP and Abdominal Fat
Adipocytes
A comparison of adipocyte histology in theMFPs and abdom-
inal fat deposits of mice, fed the two diets for 20 weeks, re-
vealed (Fig. 4) that adipocytes in the MFPs of mice fed theω-
3 diet, were approximately 45% smaller compared to MFP
adipocytes from ω-6 diet fed mice (p < 0.05) (Fig. 4a and
b). The increase in MFP adipocyte size was validated by an
analysis of the adipocyte number/100× image, which docu-
mented that the adipocyte number/field was increased 67% in
the MFPs of theω-3 diet fed group, compared to theω-6 diet
fed mice (Fig. 4a and b) (p < 0.05). Consistent with variations
in MFP adipocyte sizes, an analysis of adipocytes size and the
number of adipocytes/100× field in abdominal fat showed that
mice fed the ω-3 diet had 53% smaller adipocytes and 113%
more adipocytes per 100X field compared to iso-caloric ω-6
diet fed mice (Fig. 4c and d) (p < 0.05). We also assessed
potential mechanisms for the differences in adipocyte size.
This focused on alterations in fat storage/metabolism in the
MFP and abdominal fat between the dietary groups by ana-
lyzing the relative mRNA expression of genes associated with
fat metabolism. The results revealed that mice on theω-6 diet
had significantly increased mRNA expression for leptin (Lep)
levels (3.1-fold), insulin-like growth factor-1 (IGF1) (1.8-
fold) and IGF1 receptor (IGF1R) (1.7-fold) compared to the
MFPs from mice fed the ω-3 diet (Fig. 4e) (p < 0.05).
Similarly, mRNA analysis of the abdominal fat showed
that mice fed an ω-6 diet had significantly increased
mRNA levels of Lep (5.1-fold), IGF1 (1.9-fold) and
IGF1R (2.2-fold) compared to the mice fed diets high
in ω-3 FA. (Fig. 4f).
Dietary PUFA Regulation of Adipose Tissue
Inflammation
The MFPs, from groups of mice on the two FA diets for 10
and 20 weeks, were assessed for crown-like structures (CLS),
macrophage infiltration and expression of inflammatory cyto-
kines (Fig. 5). The number of CLS per 100 adipocytes and
Table 2 Fatty acid profiles of the diets and mammary fat pads measured by gas chromatographic mass spectrophotometry (GC-MS) analysis
Fatty Acid (FA) Name Carbon chain Diet (FA μg/ml of diet) Mammary fat pad (FA μg/mg of MFP ± SEM)
ω-3 ω-6 ω-3 ω-6
Saturated fatty acid (SFA)
Tetradecanoate C14:0 0 0.2 6.3 ± 0.7 2.8 ± 0.6
Hexadecenoic C16:0 1.53 3.02 105.3 ± 8.8 * 68.5 ± 8.3
Octadecenoic C18:0 0.28 0.76 19.8 ± 2.5 13.9 ± 2.0
Monounsaturated fatty acid (MUFA)
9-Hexadecenoic C16:1 0 0.2 18.2 ± 1.4 12.3 ± 2.4
9-Octadecenoic C18:1 3.77 15.62 166.1 ± 7.0 * 252.2 ± 31.4
cis-13-Eicosenoic C20:1 0.7 0 9.2 ± 0.5 * 3.0 ± 0.5
13-Docosenoic acid C22:1 0.25 0 1.3 ± 0.1 * 0.0 ± 0.0
Polyunsaturated fatty acid (ω-6 FA)
cis-8,11-Octadecadienoic (Linoleic) C18:2 6.67 5.03 71.3 ± 3.3 55.2 ± 7.4
cis-5,8,11,14-Eicosatetraenoic (Arachedonic acid; AA) C20:4 0.51 0 0.7 ± 0.2 0.2 ± 0.2
Polyunsaturated fatty acid (ω-3 FA)
cis-9,12,15-Octadecatrienoic acid (Linolenic) C18:3 0.14 0.24 0.7 ± 0.2 * 0.0 ± 0.0
7,10,13-Eicosatrienoic C20:3 0 0 0.7 ± 0.2 * 0.0 ± 0.0
cis-5,8,11,14,17-Eicosapentaenoic (EPA) C20:5 7.52 0 11.1 ± 1.2 * 0.0 ± 0.0
cis-4,7,10,13,16,19-Docosahexaenoic (DHA) C22:6 2.64 0 7.5 ± 0.6 * 0.0 ± 0.0
cis-4,7,10,13,16-Docosapentaenoic acid C22:5 0.26 0 1.7 ± 0.1 * 0.0 ± 0.0
Total omega 6 FA level 7.18 5.03 72 ± 3.5 55.5 ± 7.3
Total omega 3 FA level 10.56 0.24 21 ± 2.0 * 0.0 ± 0.0
Total MUFA level 4.72 15.82 193.5 ± 8.7 267.5 ± 32.6
Total SFA level 1.81 3.98 131.4 ± 11.9 * 85.3 ± 10.0
Total FA mass per mg/ml of MFP/diet 24.27 25.07 420.3 ± 20.1 442.2 ± 47.0
Ratio of total ω-6 FA toω-3 FA (ω-6:ω-3) 0.7:1 21:1 3.4:1 55.5:0
Mammary fat pads were collected from the mice fed respective diets for 10 weeks. (n = 5/group). The ready to use diets were used for FA analysis. The
results were expressed as microgram of fatty acid per milligram of MFP tissue
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infiltrating immune cells/CLS were analyzed in H& E stained
MFP sections (Fig. 5a). Mice on the ω-3 diet had 64% fewer
MFP-CLS (11.0 ± 0.8) compared to MFP-CLS (30.7 ± 3.2) in
the ω-6 diet fed mice (Fig. 5a and b) (p < 0.05). Similarly,
there was a 31% decrease in the number of infiltrating mac-
rophages per CLS i.e. (2.8 ± 0.4) compared to the number of
infiltrating macrophages (4.0 ± 0.6) cells/CLS in the MFPs
from theω-6 diet fed mice (Fig. 5a and c). Macrophage infil-
tration of MFPs was confirmed by F4/80+ staining (Fig. 5d).
This analysis revealed that mice on the ω-3 diet had 60%
fewer adipocytes with at least one adjacent F4/80+ cell/s
(1.5 ± 0.1) compared to adipocytes (5.2 ± 0.2) in the MFPs
from ω-6 diet fed mice (Fig. 5d and e) (p < 0.05). As high
levels of inflammatory mediators have been associated with
the increased numbers of CLS in adipose tissue [11], we ana-
lyzed the mRNA levels of inflammatory cytokines by qRT-
PCR. These studies revealed that the MFPs of mice fed anω-
6 diet, had higher levels of mRNA for Prostaglandin-
Endoperoxide Synthase 2 (Ptgs2) (2.3-fold), interleukin-6
(IL6) (2.0-fold), C-C motif chemokine ligand 2 chemokine
Fig. 2 Effects of Lc-ω-3FA on MG ductal branching and morphology:
MGs were analyzed for ductal termini (end-point density), lateral
branching (branching density) and sprouts in mice fed the diets for
20 weeks [n = 10/group]. Whole mounts of carmine-alum stained fourth
rear, MGs from 30-week old ω-3 diet fed mouse (a) and ω-6 diet fed
mouse diets (a) [n = 10].MGswere analyzed for the number (b). The total
ductal tree area (c), number of ductal terminus (d) and number of lateral
branches/mm of primary or secondary ducts (e). High power analysis of
ductal branches showing absence of sprouts in MFP of ω-3 diet fed
mouse (f) and presence of sprouts (shown by arrows) in MFP ofω-6 diet
fed mouse (g). Images of (a and b) are 12.5× and (f and g) are 40×
magnification. [* = p < 0.05]
50 J Mammary Gland Biol Neoplasia (2018) 23:43–58
(CCL2) (2.3-fold), interferon gamma (IFNg) (2.8-fold), NFkB
(1.5-fold) and TNFα (1.7-fold) in theMFPs fromω-6 diet fed
mice compared to ω-3 diet fed mice (Fig. 5f).
Discussion
In this study, we provided moderate fat, iso-caloric diets to
pair-fed groups of mice for 10 or 20 weeks of adult life.
Our goal was to assess the effects of dietary Lc-ω-3FAs on
the structural, inflammation and morphological alterations
and differentiation of post-pubertal murine MGs. These
studies demonstrated that a post-pubertal exposure to
Lc-ω-3FAs modulates mammary gland FA composition;
lateral branching, ductal epithelial proliferation and
adipose tissue inflammation relative to the mice fed ω-6
diet, which contained high levels of ω-6 FA and oleic acid
but lacked Lc-ω-3FAs.
A difference in dietary consumption (likely due to palat-
ability) may be a factor when analyzing effects specific to the
dietary composition, independent of total caloric intake or
obesity [17]. We report that mice fed an ω-6 diet consumed
significantly more liquid diet compared to theω-3 diet during
a 5-day initial ad libitum feeding period. This difference was
subsequently controlled by pair feeding based on consump-
tion of the ω-3 diet. Despite pair feeding and isocaloric and
isolipidic diet consumption, the inclusion of Lc-ω-3FA in the
diet significantly decreased body weight gains and abdominal
fat deposits (−45%) in mice. These results are consistent with
prior studies comparing diets high in ω-3 or ω-6 FA [6, 17].
Fig. 3 Effects of Lc-ω-3FA on MG ductal thickness and epithelial cell
proliferation: Mammary ductal histology analyzed in trichrome stained
MFP sections, using 200× images (n = 10fields/mouse from five
mice/group). In each duct, the area of lumen marked as (DL),
epithelium (DE) and stroma or connective tissue (DS) were analyzed as
illustrated (a). Masson’s trichrome stained MFP from ω-3 diet fed mice
(b) andω-6 diet fed mice (c). The difference in the area of ductal stroma
(d), ductal epithelium (e), stroma relative to luminal area (f) and epithelial
area relative to luminal area (g) were analyzed. MFP sections stained with
the anti-Ki67 antibody were analyzed for Ki67+ proliferating ductal epi-
thelial cells (h). Images showing Ki67+ cells in ducts of MFP from ω-3
diet fed mouse (i) and ω-6 mouse (j). Relative mRNA expression (fold
change compared to theω-3 group) of ESR1 and AREG in MFP of mice
fed the ω-6 diet for 20 weeks (n = 15/group) [# = p < 0.05 compared to
the ω-3 group]. Images were taken at a magnification of 200× (a and f)
[* = p < 0.05]
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In addition, studies have reported a 50% reduction in retroper-
itoneal fat mass [22], and a 25% reduction in epididymal fat
deposits in mice fed a high ω-3 FA diet [23]. This suggests
that dietary Lc-ω-3FA are associated with the regulation of fat
mass via stimulatory or inhibitory roles of ω-6 FA and ω-3
FA metabolites respectively in the differentiation of adipo-
cytes [24, 25]. Further, increasing β-oxidation and suppres-
sion of lipogenic enzymes, such as leptin in adipose tissue,
may provide potential mechanisms for reducing body fat by
ω-3 FA exposures [26, 27].
To analyze the effects of dietary PUFA in MGs, we com-
pared MFP weights of the fourth MG, after feeding the diets
for 20 weeks, and observed 43% lighter MFPs inmice on aω-
3 diet as compared to theω-6 diet group. This was associated
with the novel observation of a significant higher incorpora-
tion of Lc-ω-3FAs in the MFPs from ω-3 diet fed mice as
compared to theMFPs fromω-6mice. Theω-6 andω-3 diets
used in the present study contained a ω-6:ω-3 ratio of 21:1
and 0.7:1 respectively. The only ω-3 FA in the ω-6 diet was
Linolenic acid (ALA), whereas Lc-ω-3FAs such as EPA and
DHAwere prominentω-3 FAs in the MGs of theω-3 diet fed
mice (Table 2). Thus, our results document that the incorpo-
ration of Lc-ω-3FAs in MFP depends directly on the dietary
intake rather than in vivo conversion toω-3 FAs from dietary
ALA. We note that dietary ALA can be endogenously con-
verted to Lc-ω-3FAs in mammals; however, the process is not
efficient and < 5% of ALA consumed is converted to Lc-ω-
3FAs in humans [28]. The observation might explain the lack
of Lc-ω-3FA in the MFPs of mice fed the ω-6 diet. The
Lc-ω-3FA levels of mammary adipose tissue might be of clin-
ical relevance as the breast adipose tissue from breast cancer
patients has significantly higher and lower levels of ω-6 FA
Fig. 4 Effects of Lc-ω-3FA on adipocytes histology and metabolic gene
expression: Analysis of adipocytes in H & E stained mammary fat pad
(MFP) (a) by measuring an average adipocyte size (area) and the number
of adipocytes per 100× field (b) [10 fields/mouse in five mice]. H and E
stained sections of abdominal fat (c), adipocyte size and the number of
adipocytes per 200× field (d) [n = 10 fields/mouse in five mice]. Relative
mRNA expression (fold change compared to ω-3) of leptin, IGF1, and
IGF1R inMFP (e) [n = 15/group] and an abdominal fat of mice fed anω-
6 diet for 20 weeks (f) [n = 8/group] [# = p < 0.05 compared to ω-3
group]. Images were taken at a magnification of 100× (a and c) [* = p
< 0.05]
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and Lc-ω-3FA respectively [29, 30]. Besides the differences
inω-3 andω-6 FA composition between the diets, the level of
oleic acid was significantly higher inω-6 diet and in MFPs of
mice fed ω-6 diet compared to the levels in the ω-3 group.
However, there is no significant data on oleic acid regulation
of inflammation and mammary gland density published.
Rather, oleic acid is known to prevent inflammation in adipose
tissue [31]. Thus, we believe the alterations in outcomes be-
tween the dietary groups, are potentially due to the differences
in Lc-ω-3FA levels between the diets.
Although MFP weights may be a gross indicator of MG
density in animal models, significant differences in MG adi-
posity might influence the MG weights. Pubertal exposure to
HF diets has been shown to result in heavier MGs and stunted
development in C57BL/6 mice due to higher adiposity [1],
while in-utero exposure to an HF-ω-6 diet increased the
TEB number and enhanced susceptibility to carcinogenesis
in BALB/c mice [32]. Our data suggest that the observed
difference in MFP weight might be the result of combined
effects by the difference in MFP adipocyte size and alterations
in MG glandular structure and composition including ductal
epithelial cells proliferation and leucocytes infiltration be-
tween the dietary groups. MG development is age-dependent
such that MGs undergo extensive modeling and remodeling
during fetal development, puberty and pregnancy. The major-
ity of dietary intervention studies use pre-pubertal mice that
have a correlation between a higher number of TEBs and an
increased risk of cancer [1, 16, 32]. However, in this study we
used post-pubertal mice whose TEBs had differentiated into
terminal ducts. Despite the post pubertal status, we observed
that feeding an ω-3 diet in early adulthood (10–30 weeks of
age) was associated with a decreased number of ductal termi-
ni, lateral branching of primary and secondary ducts, and a
different total ductal area compared to isocaloric, isolipdicω-
6 diet fed mice. Previous studies, based on ω-3 diets using a
LF-ω-3 (16% energy) diet in pre-pubertal mice [16] and off-
spring of HF-ω-3 (39% energy) diet fed mice, had a reduced
number of TEB associating with the lower risk of tumorigen-
esis compared to same fat level ω-6 dietary group [33].
However, when HF-ω-3 (39% energy) were compared to
LF-ω-6 (16% energy), the former developed more TEB and
an increase in tumorigenesis compared to the latter,
Fig. 5 Effects of Lc-ω-3FA on adipose tissue inflammation: Analysis of
crown-like-structures (CLS) in H & E stained mammary fat pad (MFP)
(a) [n = 10 fields/mouse from five mice/group]. Number of CLS per 100
adipocytes (b) and the number of inflammatory cells per CLS (c) were
compared. Macrophages infiltration analyzed in F4/80 stained MFP sec-
tions (d) [n = 10 fields/mouse in five mice]. The number of adipocytes
surrounded by at least one F4/80+ cell/s were counted in 200× field (e)
Relative mRNA expression (fold change compared toω-3) of inflamma-
tory mediators, such as ptgs2, IL6, CCL2, IFNγ NFκB and TNFα in
MFP of mice fed the ω-6 diet for 20 weeks (f) (n = 15/group) [# = p <
0.05 compared to ω-3 group). Images were taken at a magnification of
400× (a) and 200× (d) respectively. [* = p < 0.05]
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emphasizing the differential effects of fat-calories vs fat com-
position of the diets in MG differentiation and tumorigenesis
[16]. Since we used an iso-caloric diet and pair-feeding, our
observation of differences are indicative of the regulation of
MG structure and morphology by dietary Lc-ω-3FA, indepen-
dent of caloric intake and obesity. Total ductal tree area and
ductal end-point and branching density represents epithelial
and stromal mass of MG in animals, which can be considered
equivalent to breast density as shown by mammographic scans
in humans [20, 34]. Animal and clinical studies showedMG or
breast density as a predictor of carcinogenic response or breast
cancer risk [7, 35], while an increase in plasma DHA was
associated with a decreased breast density in obese, postmeno-
pausal women [36]. We did not observe a significant difference
in ductal lengths between the dietary groups, which might be
due to the age of the mice (post-pubertal) at the start of the diet,
since mice at this age have already gained full primary duct
length, as a result of the extension which occurs mostly during
pubertal age [6]. Rather, the effects of the diets alter the fre-
quency of lateral branches, ductal terminus and formation of
ducts (shown by a presence of sprouts in ducts inω-6 diet fed
mice) and likely the total epithelial mass of MG. Further, future
studies will need to evaluate the effects of dietary PUFA com-
position in mammary tumor growth and metastasis.
The observation of structural and morphological alterations
in MG ductal trees was confirmed by immune-histological
analysis of MG ducts. Mice fed theω-3 diet had significantly
smaller ducts, and a thinner layer of epithelium and connective
tissue (stroma) in the ductal wall, as compared to the ducts
from the ω-6 group. Since there was a difference in ductal
size, we further evaluated those parameters relative to the
ductal luminal area and found that the difference in the stroma
was independent of ductal size, but the differences in epithe-
lium thickness might be secondary to the ductal size.
However, a significant decrease in proliferating ductal epithe-
lial cells in theω-3 group suggests a regulatory role of Lc-ω-
3FA in mammary epithelial cells proliferation. Our observa-
tions of an increased ductal stroma and proliferating ductal
epithelial cells inMFPs frommice receiving theω-6 diet were
in agreement with previous reports that showed higher stromal
density [37] and proliferating epithelial cells [38] in mammary
ducts of mice fed high fat-diet. However, effects of isocaloric
PUFA diets and/or dietary Lc-ω-3FA in ductal stromal tissue
have not been reported before.
Evidence from clinical studies showed that women with
cytological atypia had a higher ratio ofω-6:ω-3 FA in breast
tissue [39], which was associated with a reduced number of
Ki-67+ cells with increased levels of Lc-ω-3FA in erythrocyte
phospholipids [40]. Further, animal studies have shown that
pre-pubertal exposure to low-fat (LF)-ω-3 was able to reduce
chemical induced tumorigenesis [16] and inhibit atypical duc-
tal hyperplasia at early stages of mammary carcinogenesis
[41]. In addition, a recent finding of the regression of
established pre-neoplastic lesions, by combined treatment of
fish oil and tamoxifen and its correlation with tissue levels of
Lc-ω-3FA, demonstrated preventive and therapeutic roles of
dietary Lc-ω-3FA in MG malignancies [42].
In our studies we detected estrogen receptors in the MFPs,
consistent with prior reports of their presence on adipocytes
and fibroblasts, within MFPs. This supports the critical role of
estrogen receptors in epithelial proliferation, mediated by both
endocrine-derived and locally produced estrogen [12, 43, 44].
We also studied message levels of AREG, a ligand for epider-
mal growth factor receptor (EFGR), which is induced by es-
trogen binding to estrogen receptor alpha (ESR1) stimulating
the proliferation of mammary epithelium. Further, the overex-
pression of AREG has been associated with mammary tumor-
igenesis [45, 46]. Recent studies have shown estrogen stimu-
lated ductal side branching by enhancing IGF-I action, while
an overexpression of IGF-I was associated with ductal hyper-
plasia [47, 48] as observed in our studies. Further, both estro-
gen and IGF-I are required for progesterone-mediated forma-
tion of mature mammary gland alveoli. Thus our observation
of increased lateral branching, stromal thickness and epithelial
proliferation in mice fed theω-6 diet might be due to additive
effects of IGF-I to estrogen signaling, as shown by significant
higher expression of AREG and ESR1 respectively in MFPs
ofω-6 diet fed mice. However, as there were no differences in
progesterone receptor mRNA expression in the MFPs. These
observations indicate progesterone message levels might have
little effect on lateral branching of the ducts in virgin, nullip-
arous adult mice.
We also assessed the effects of PUFA on adipocytes, which
may regulate MG ductal morphogenesis. Adipocyte hypertro-
phy is one mechanism for storing excess energy, and has been
observed in both omental and subcutaneous fat of obese
humans [49], and in HF, high calorie-fed animals, [50] and
genetically susceptible animals [51]. In our studies, we used
moderate fat (MF), iso-caloric diets and a pair-fed model in
BALB/c mice, which are known to be less susceptible to obe-
sity [52]. Thus, our observation of significantly smaller adi-
pocytes in abdominal and mammary adipose tissue fromω-3
mice suggests differential regulation of lipid metabolism, stor-
age and/or beta-oxidation in adipose tissue by dietaryω-3 and
ω-6 FAs [53–55]. Studies showed thatω-6 FAs consumption
triggered adiposity in human [56] and rodents [57] potentially
by promoting pre-adipocyte differentiation or adipogenesis
[58], while DHA was able to inhibit differentiation to adipo-
cytes and promote lipolysis [59]. In this study, theω-3 diet fed
group had significantly higher number of adipocyte per mi-
croscopic field, which further validates our observation of a
smaller adipocytes in ω-3 group. However, since we did not
analyze a total adipocytes number per MFP or abdominal fat,
further studies are required to analyze PUFA regulation of
adipogenesis in this pair-fedmodel. Further, prior reports have
shown that EPA can reduce hypertrophy of abdominal
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adipocytes [50, 60]. However, the role of Lc-ω-3FAs in de-
creasing MFP adipocyte hypertrophy, have not been done
previously, even though adipocytes have been actively
researched for their crucial role in MG growth, development
and carcinogenesis [12].
Adipocytes’ size and fat mass are important determi-
nants in adipokine regulation of energy homeostasis.
Leptin (Lep) expression increases with adipocyte size
[61] and fat mass [62], while adiponectin (Adipoq) expres-
sion is inversely correlated with obesity [63]. However, the
fat deposit distribution depends on the levels of leptin ex-
pression [64]. Leptin is a hormone of satiety; however,
elevated plasma leptin levels do not induce a reduction of
food intake nor increased energy expenditure in obese peo-
ple, due to development of leptin resistance [65]. Although
the mouse strain we used is less sensitive to obesity [66],
the absence of Lc-ω-3FA in the ω-6 diet led mice to gain
adipose tissue resulting in a significant increase in Lep and
no effects on Adipoq expression in abdominal fat tissue
and MFP. Our results in Lep expression are in agreement
with prior studies using HF diets with and without EPA
[62, 67], while no effect in Adipoq might be due to dietary
FA levels, mouse strain, or type of adipose tissue analyzed.
Fish oil was able to induce epididymal adipose tissue but
not subcutaneous adipose tissue [68]. Besides their role in
lipid homeostasis, leptin levels have been associated with
the induction of pro-inflammatory cytokines [69], and en-
hanced proliferation of normal and malignant breast epi-
thelial cells [70].
In addition, we observed that a lack of dietary Lc-ω-3FAs
significantly enhanced expression of IGF1 and IGF1R in
MFPs and abdominal fat. IGF1 was originally believed to be
exclusively produced by the liver [71], but a recent study [72]
showed IGF1 secretion by adipocytes and M2-macrophages.
Further, ablation of IGF1R from myeloid cells results in ele-
vated adiposity, lowered energy expenditure and increased
macrophage infiltration into adipose tissue, and reduced
phagocytosis [72, 73]. While IGF1 is synthesized by MG
adipocytes and promotes the growth of ductal epithelium
[74], overexpression of IGF1R can induce mammary epithe-
lial hyperplasia in transgenic mice (containing human IGF-IR
under a doxycycline-inducible MMTV promoter) [75] and is
associated with increased risk of mammary cancer [76]. Our
results are consistent with a prior study, which showed a
negative correlation of dietary ω-3 FA with plasma IGF1
expression and ductal density [7]. However, the effects of
ω-3 in local IGF1 expression in MG and other adipose
tissue have not been previously reported; thus, our results
indicate a need for additional investigation. Further, the
similarities in IGF1 expression, in both MFP and abdomi-
nal fat, but differential expression pattern of IGF1R, indi-
cates morphological similarities between adipocytes, but
potentially different mechanisms of signaling.
Recent studies suggest that white blood cells, notably mac-
rophages and eosinophils, are attracted to the end bud [77] and
are essential for their development [77]. This finding raises a
question regarding the regulatory role of chronic local/adipose
tissue inflammation in MG pathology. Further, macrophages
may also have a role in other attributes of MGmorphogenesis
such as lateral branching, terminal ducts, and ductal sprout
formation, potential mechanisms requiring additional study.
In the studies reported herein, we observed that the number/
size of CLS and the number of macrophages infiltrating MGs
were significantly lower inMFPs ofω-3 diet fed mice. CLS is
a hallmark of chronic adipose tissue inflammation, and in-
creased numbers of CLS in the breast (CLS-B) have been
associated with increased risk and poor prognosis of breast
cancer patients in both obese individuals and those with nor-
mal BMI [78, 79]. CLS formation has been shown to enhance
the expression of inflammatory cytokines/chemokines poten-
tially, further activating macrophages for clearing of apoptotic
adipocytes. We observed significantly increased expression of
P tgs2 , NFkB, IL6 , IFNγ , and the macrophage
chemoattractant; CCL2 in the MFP of ω-6 diet fed mice.
These findings support an increase in pro-inflammatory sig-
naling byω-6 FAs and its metabolite, AA in the MFP micro-
environment. In these studies, the AA levels in the MGs did
not differ between theω-6 andω-3 diet groups; however, the
MFP from ω-6 diet mice did not have detectable levels of
Lc-ω-3FA. Thus, our results suggested that the lack of detect-
able Lc-ω-3FA is more crucial relative to the levels of AA for
chronic inflammation. Local Lc-ω-3FA has been shown to
exert anti-inflammatory and anti-chemotactic activity regulat-
ing adipose tissue inflammation [80]. Further, constitutive ex-
pression of CCL2 by mouse mammary epithelium has been
reported to increase stromal density and increase mammary
tumor susceptibility [81], emphasizing a potential role of
chronic inflammation in ductal epithelial proliferation and car-
cinogenesis that could be modified by dietary ω-3 FAs.
Findings from epidemiological, and animal studies using
HF-fed or genetically obese models have provided contradic-
tory results regarding the role of dietary Lc-ω-3FA in the MG
microenvironment and morphogenesis, depending on the age
of mice and mixed effects of dietary calories versus composi-
tion. In summary, this research shows that dietary Lc-ω-3FA
reduces MG density by decreasing ductal end-point density,
branching density, ductal stroma and epithelial prolifera-
tion in adult mice. This occurred in an amphiregulin-
estrogen and IGF-I dependent manner, potentially by
modulating adipocyte metabolism and adipose tissue in-
flammation. Further, an absence of detectable levels of
Lc-ω-3FA, such as EPA and DHA in MG, might be an
indicator of inflammation-associated pathologies. Future,
mechanistic studies using tumor models are justified to
assess a role for dietary Lc-ω-3FA inhibition of mammary
tumor development in adults.
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